×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RVPH – reviva pharmaceuticals holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RVPH
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/29
08:12 am
rvph
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum [Yahoo! Finance]
Medium
Report
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum [Yahoo! Finance]
12/29
08:00 am
rvph
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
High
Report
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
12/24
08:02 am
rvph
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
High
Report
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
12/23
09:02 am
rvph
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia [Yahoo! Finance]
Medium
Report
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia [Yahoo! Finance]
12/23
08:42 am
rvph
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $2.00 price target on the stock.
Medium
Report
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $2.00 price target on the stock.
12/23
08:00 am
rvph
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
High
Report
Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia
12/16
03:26 am
rvph
Reviva Pharmaceuticals: Brilaroxazine Seems Efficacious, But Progress Is Slow And Dilution Is High [Seeking Alpha]
Low
Report
Reviva Pharmaceuticals: Brilaroxazine Seems Efficacious, But Progress Is Slow And Dilution Is High [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2025
04:05 pm
RVPH
reviva pharmaceuticals holdings, inc.
BEAT
Report
-10.5%
reviva pharmaceuticals holdings, inc.
8/14/2025
04:25 pm
RVPH
reviva pharmaceuticals holdings, inc.
BEAT
Report
17.0%
reviva pharmaceuticals holdings, inc.
5/15/2025
04:05 pm
RVPH
reviva pharmaceuticals holdings, inc.
BEAT
Report
-3.5%
reviva pharmaceuticals holdings, inc.
Date
Time
Symbol
Headline
Impact
12/23
08:05 am
rvph
Form 8-K REVIVA PHARMACEUTICALS For: Dec 18
High
Report
Form 8-K REVIVA PHARMACEUTICALS For: Dec 18
12/22
04:30 pm
rvph
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: SAXENA PARAG
High
Report
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: SAXENA PARAG
12/19
04:18 pm
rvph
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Funtleyder Leslie D.
Low
Report
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Funtleyder Leslie D.
12/19
04:18 pm
rvph
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Patel Purav
Low
Report
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Patel Purav
12/19
04:18 pm
rvph
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Margolin Richard A
Low
Report
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Margolin Richard A
12/19
04:17 pm
rvph
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: SAXENA PARAG
Low
Report
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: SAXENA PARAG
12/12
04:53 pm
rvph
Form 25-NSE REVIVA PHARMACEUTICALS Filed by: Nasdaq Stock Market LLC
Medium
Report
Form 25-NSE REVIVA PHARMACEUTICALS Filed by: Nasdaq Stock Market LLC
12/5
04:19 pm
rvph
Form DEFA14A REVIVA PHARMACEUTICALS
Low
Report
Form DEFA14A REVIVA PHARMACEUTICALS
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: